1. Home
  2. NWN vs HRMY Comparison

NWN vs HRMY Comparison

Compare NWN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NWN

Northwest Natural Holding Company

HOLD

Current Price

$46.77

Market Cap

2.0B

Sector

Utilities

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.80

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWN
HRMY
Founded
1859
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NWN
HRMY
Price
$46.77
$36.80
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$49.50
$49.75
AVG Volume (30 Days)
241.2K
615.1K
Earning Date
02-27-2026
02-24-2026
Dividend Yield
4.18%
N/A
EPS Growth
20.18
50.44
EPS
2.47
3.17
Revenue
$1,266,082,000.00
$825,944,000.00
Revenue This Year
$15.18
$23.29
Revenue Next Year
$6.55
$15.98
P/E Ratio
$19.04
$11.58
Revenue Growth
11.27
21.13
52 Week Low
$38.94
$25.52
52 Week High
$49.63
$40.93

Technical Indicators

Market Signals
Indicator
NWN
HRMY
Relative Strength Index (RSI) 50.37 48.42
Support Level $46.35 $35.16
Resistance Level $47.16 $37.08
Average True Range (ATR) 0.78 1.43
MACD 0.06 -0.21
Stochastic Oscillator 58.31 43.22

Price Performance

Historical Comparison
NWN
HRMY

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: